EP 3137107 A4 20180117 - COMBINATION IMMUNO THERAPY AND RADIOTHERAPY FOR THE TREATMENT OF HER-2-POSITIVE CANCERS
Title (en)
COMBINATION IMMUNO THERAPY AND RADIOTHERAPY FOR THE TREATMENT OF HER-2-POSITIVE CANCERS
Title (de)
IMMUNKOMBINATIONSTHERAPIE UND RADIOTHERAPIE ZUR BEHANDLUNG VON HER-2-POSITIVEN KARZINOMEN
Title (fr)
IMMUNOTHÉRAPIE ET RADIOTHÉRAPIE COMBINÉES POUR LE TRAITEMENT DE CANCERS POSITIFS À HER-2
Publication
Application
Priority
- US 201414268436 A 20140502
- US 201462076411 P 20141106
- US 2015017559 W 20150225
- US 201514669629 A 20150326
- US 2015024048 W 20150402
Abstract (en)
[origin: WO2015167748A1] This invention provides methods for inducing an immune response against a Her-2/neu antigen-expressing tumor and for treating the same and vaccinating against the same in human and canine subjects using a combination of radiation therapy and a recombinant attenuated Listeria strain vaccine.
IPC 8 full level
C12N 1/12 (2006.01); A61K 39/00 (2006.01); C12N 1/20 (2006.01)
CPC (source: EP KR US)
A61K 39/0011 (2013.01 - EP KR); A61K 39/001106 (2018.08 - EP KR US); A61P 11/00 (2018.01 - EP); A61P 19/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/04 (2018.01 - EP); A61P 43/00 (2018.01 - EP); A61K 2039/522 (2013.01 - EP KR); A61K 2039/523 (2013.01 - EP KR); A61K 2039/545 (2013.01 - EP KR); A61K 2039/552 (2013.01 - EP KR)
Citation (search report)
- [Y] WO 2011100754 A1 20110818 - UNIV PENNSYLVANIA [US], et al
- [A] WO 2011149852 A1 20111201 - ADURO BIOTECH [US], et al
- [A] US 2005281783 A1 20051222 - KINCH MICHAEL S [US], et al
- [Y] CRISTER CEBERG ET AL.: "Co-operative radio-immune-stimulating cancer therapy", TRENDS IN CANCER RESEARCG, 2013, pages 87 - 108, XP002776527, Retrieved from the Internet <URL:https://www.researchgate.net/profile/Bertil_Persson/publication/260291271_Co-operative_Radio-Immune-Stimulating_Cancer_Therapy/links/0a85e530ccf9777133000000.pdf> [retrieved on 20171208]
- [A] HANNAN RAQUIBUL ET AL: "Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer", CANCER IMMUNOLOGY IMMUNOTHERAPY, vol. 61, no. 12, December 2012 (2012-12-01), pages 2227 - 2238, XP002776528
- See also references of WO 2015167748A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015167748 A1 20151105; AU 2015253737 A1 20161222; CA 2947677 A1 20151105; CN 106794234 A 20170531; EP 3137107 A1 20170308; EP 3137107 A4 20180117; IL 248704 A0 20170131; JP 2017514904 A 20170608; KR 20170002552 A 20170106; MA 39942 A 20170308; MX 2016014367 A 20170630; SG 11201609135V A 20161129
DOCDB simple family (application)
US 2015024048 W 20150402; AU 2015253737 A 20150402; CA 2947677 A 20150402; CN 201580036168 A 20150402; EP 15786740 A 20150402; IL 24870416 A 20161102; JP 2017509588 A 20150402; KR 20167033949 A 20150402; MA 39942 A 20150402; MX 2016014367 A 20150402; SG 11201609135V A 20150402